France vs Tunisia: Previously treated cases tested for RR-/MDR-TB
France
4.2%
in 2024
Tunisia
0.0%
in 2022
France rank
170th
Tunisia rank
173rd
Previously treated cases tested for RR-/MDR-TB over time
- France
- Tunisia
How they compare
France currently reports 4.2% against 0.0% in Tunisia, a difference of 4.2%.
The two have swapped places 4 times across 11 shared years of data; in 2010 it was France ahead.
France ranks 170th and Tunisia ranks 173rd of 180 countries.
Across the 2 decades both report, France averaged higher in 1 and Tunisia in 1.
Head to head by decade
| Decade | France | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.6% | 63.1% | 20.5% | France |
| 2020s | 8.9% | 64.7% | 55.7% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, France or Tunisia?
- France, at 4.2% against 0.0% in Tunisia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between France and Tunisia?
- 4.2%, with France ahead.
- How many years of comparable data are there for France and Tunisia?
- 11 years are reported by both, from 2010 to 2022.
- How do France and Tunisia rank globally for previously treated cases tested for rr-/mdr-tb?
- France ranks 170th and Tunisia ranks 173rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.